Correlation Between Belite Bio and POTOMAC
Specify exactly 2 symbols:
By analyzing existing cross correlation between Belite Bio ADR and POTOMAC ELEC PWR, you can compare the effects of market volatilities on Belite Bio and POTOMAC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Belite Bio with a short position of POTOMAC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Belite Bio and POTOMAC.
Diversification Opportunities for Belite Bio and POTOMAC
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Belite and POTOMAC is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Belite Bio ADR and POTOMAC ELEC PWR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on POTOMAC ELEC PWR and Belite Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Belite Bio ADR are associated (or correlated) with POTOMAC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of POTOMAC ELEC PWR has no effect on the direction of Belite Bio i.e., Belite Bio and POTOMAC go up and down completely randomly.
Pair Corralation between Belite Bio and POTOMAC
Given the investment horizon of 90 days Belite Bio ADR is expected to under-perform the POTOMAC. In addition to that, Belite Bio is 1.72 times more volatile than POTOMAC ELEC PWR. It trades about -0.02 of its total potential returns per unit of risk. POTOMAC ELEC PWR is currently generating about 0.21 per unit of volatility. If you would invest 8,330 in POTOMAC ELEC PWR on November 28, 2024 and sell it today you would earn a total of 434.00 from holding POTOMAC ELEC PWR or generate 5.21% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 71.43% |
Values | Daily Returns |
Belite Bio ADR vs. POTOMAC ELEC PWR
Performance |
Timeline |
Belite Bio ADR |
POTOMAC ELEC PWR |
Belite Bio and POTOMAC Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Belite Bio and POTOMAC
The main advantage of trading using opposite Belite Bio and POTOMAC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Belite Bio position performs unexpectedly, POTOMAC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in POTOMAC will offset losses from the drop in POTOMAC's long position.Belite Bio vs. Anebulo Pharmaceuticals | Belite Bio vs. Mineralys Therapeutics, Common | Belite Bio vs. AN2 Therapeutics | Belite Bio vs. Aerovate Therapeutics |
POTOMAC vs. CVR Partners LP | POTOMAC vs. Genuine Parts Co | POTOMAC vs. American Vanguard | POTOMAC vs. MYT Netherlands Parent |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Stocks Directory Find actively traded stocks across global markets | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |